Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Syed Ali Ahsan, Kassem Chendeb, Christos Profyris, Charles Teo & Michael E. Sughrue. (2019) Pharmacotherapeutic options for atypical meningiomas. Expert Opinion on Pharmacotherapy 20:15, pages 1831-1836.
Read now
Read now
Mikkel Christian Alanin, Camilla Klausen, Per Caye-Thomasen, Carsten Thomsen, Kaare Fugleholm, Lars Poulsgaard, Ulrik Lassen, Morten Mau-Sorensen & Kenneth Francis Hofland. (2016) Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series. International Journal of Neuroscience 126:11, pages 1002-1006.
Read now
Read now
Articles from other publishers (18)
Lijian Zhang, Luxuan Wang, Yanli Tan, Chunhui Li & Chuan Fang. (2022) Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis. Medical Oncology 40:1.
Crossref
Crossref
Farshad Nassiri, Justin Z Wang, Karolyn Au, Jill Barnholtz-Sloan, Michael D Jenkinson, Kate Drummond, Yueren Zhou, James M Snyder, Priscilla Brastianos, Thomas Santarius, Suganth Suppiah, Laila Poisson, Francesco Gaillard, Mark Rosenthal, Timothy Kaufmann, Derek S Tsang, Kenneth Aldape & Gelareh Zadeh. (2022) Consensus core clinical data elements for meningiomas (v2021.1). Neuro-Oncology 24:5, pages 683-693.
Crossref
Crossref
Priya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, Marc C Chamberlain, David Schiff, Patrick Y Wen, Fabio Massaiti Iwamoto, Demirkan Besim Gursel, David A Reardon, Benjamin Purow, Masha Kocherginski, Irene Helenowski & Jeffrey J Raizer. (2022) A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances 4:1.
Crossref
Crossref
Tao Yu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Andreas Mock, Cihan Erkut, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende & Gerhard Jungwirth. (2021) Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers 13:23, pages 5898.
Crossref
Crossref
Amina Soltani, Bela Kajtar, El Husseiny Mohamed Mahmud Abdelwahab, Anita Steib, Zsolt Horvath, Laszlo Mangel, Luca Jaromi & Judit E. Pongracz. (2021) Is an Immunosuppressive Microenvironment a Characteristic of Both Intra- and Extraparenchymal Central Nervous Tumors?. Pathophysiology 28:1, pages 34-49.
Crossref
Crossref
Lianhua Zhao, Wei Zhao, Yanwei Hou, Cuixia Wen, Jing Wang, Pei Wu & Zaiyu Guo. (2020) An Overview of Managements in Meningiomas. Frontiers in Oncology 10.
Crossref
Crossref
Jie Tang, Liwei Zhang, Junting Zhang, Zhen Wu, Xinru Xiao, Dabiao Zhou, Guijun Jia & Wang Jia. (2016) Microsurgical management of primary jugular foramen meningiomas: a series of 22 cases and review of the literature. Neurosurgical Review 39:4, pages 671-683.
Crossref
Crossref
Jeffrey Raizer & Simran Singh. 2016. International Neurology. International Neurology
579
581
.
Melissa Schmidt, Andreas Mock, Christine Jungk, Felix Sahm, Anna Theresa Ull, Rolf Warta, Katrin Lamszus, Konstantinos Gousias, Ralf Ketter, Saskia Roesch, Carmen Rapp, Sebastian Schefzyk, Steffi Urbschat, Bernd Lahrmann, Almuth F. Kessler, Mario Löhr, Christian Senft, Niels Grabe, David Reuss, Philipp Beckhove, Manfred Westphal, Andreas von Deimling, Andreas Unterberg, Matthias Simon & Christel Herold-Mende. (2016) Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade. Oncotarget 7:12, pages 14551-14568.
Crossref
Crossref
Malika L. Siker, Joseph Bovi & Brian Alexander. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
521
540.e5
.
H. Maximilian Mehdorn. 2016. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery
139
184
.
Evrim Önder, Ata Türker Arıkök, Hakan Seçkin & Murat Alper. (2015) Decrease in serine protease HtrA1 expression correlates with grade and recurrence in meningiomas. Advances in Medical Sciences 60:1, pages 139-143.
Crossref
Crossref
L. E. Kwee, M. L. C. van Veelen-Vincent, E. M. C. Michiels, J. M. Kros & R. Dammers. (2014) The importance of microsurgery in childhood meningioma: a case report. Child's Nervous System 31:1, pages 161-165.
Crossref
Crossref
Shawn L. Hervey-Jumper & Mitchel S. Berger. 2015. Emergency Approaches to Neurosurgical Conditions. Emergency Approaches to Neurosurgical Conditions
1
26
.
Ronald Koschny, Christina Boehm, Martin R. Sprick, Tobias L. Haas, Heidrun Holland, Li-Xin Xu, Wolfgang Krupp, Wolf C. Mueller, Manfred Bauer, Thomas Koschny, Marius Keller, Peter Sinn, Juergen Meixensberger, Henning Walczak & Tom M. Ganten. (2014) Bortezomib Sensitizes Primary Meningioma Cells to TRAIL-Induced Apoptosis by Enhancing Formation of the Death-Inducing Signaling Complex. Journal of Neuropathology & Experimental Neurology 73:11, pages 1034-1046.
Crossref
Crossref
Ulrike Mock, Dietmar Georg, Lukas Sölkner, Christian Suppan, Stanislav M. Vatnitsky, Birgit Flechl, Ramona Mayer, Karin Dieckmann & Barbara Knäusl. (2014) Assessment of improved organ at risk sparing for meningioma: Light ion beam therapy as boost versus sole treatment option. Radiotherapy and Oncology 111:3, pages 451-456.
Crossref
Crossref
Vinay Gupta, Wilson I. Gonsalves & Steven I. Robinson. (2013) Metastatic Meningioma Presenting as Cancer of Unknown Primary. Rare Tumors 5:4, pages 192-193.
Crossref
Crossref
Alan A. MoazzamNaveed Wagle & Gabriel Zada. (2013) Recent developments in chemotherapy for meningiomas: a review. Neurosurgical Focus 35:6, pages E18.
Crossref
Crossref